To oversee the Epilepsy Ventures Fund (EVF), the Foundation has assembled a wide array of private and philanthropic partners who have come together to improve outcomes for people living with the epilepsies.

EVF is led by our expert board of directors and advisors, and leverages the Epilepsy Foundation’s internal expertise, broad volunteer advisory councils, and credibility within the epilepsy community.

EVF Board of Directors

Greg Mayes
 

Greg Mayes
CEO, Antios Therapeutics
Board Chairman, EVF

John Dawson
 

John Dawson
CEO, Oxford Biomedica

 

Frank Fischer
 

Frank Fischer
Board Chairman, Neuropace

Laura Thrall
 

Laura Thrall
CEO, Epilepsy Foundation

 

 

Bob Smith
 

Robert Smith
Private Investor, Retired Fund Manager

 

 

Advisors to the Fund

 

 

Andy Smith
 

Andy Smith
Vice President, Oak HC/FT

Joe Morris
 

Joe Morris
Managing Director, Canal Pointe Capital

 

Legal Counsel

 

Schaner & Lubitz
Ken Schaner and David Lubitz are leaders in venture philanthropy, representing some of the largest ventures in the healthcare nonprofit field.